杨 卓
曲安奈德联合甲硝唑灌肠治疗溃疡性直肠炎疗效观察
杨 卓
【摘要】目的 对曲安奈德联合甲硝锉灌肠治疗溃疡性直肠炎的具体疗效进行观察与探讨。方法 从2015年12月~2016年2月至我院诊治的溃疡性直肠炎患者中选出50例,采用随机数字表法将其均分为观察组与对照组,每组25例患者。观察组患者给予曲安奈德联合甲硝锉的灌肠治疗方法,对照组患者给予甲硝锉灌肠治疗方法。本研究为期7天,治疗后观察两组患者的临床症状缓解情况,并对两组患者的血清炎性因子进行检测与对比。结果 观察组患者的临床症状缓解情况优于对照组患者,其血清白细胞介素8的水平低于对照组患者,白细胞介素10的水平则高于对照组,两者比较差异均具有统计学意义(P<0.05)。结论 曲安奈德联合甲硝锉灌肠治疗能够有效缓解溃疡性直肠炎患者的临床症状。
【关键词】溃疡性直肠炎;曲安奈德;疗效观察
Objective The research is to observe and investigate the specific effect of triamcinolone acetonide combined with metronidazole in the enema treatment of ulcerative proctitis. Methods We selects 50 cases of patients with ulcerative procititis who got diagnosis and treatment in the hospital from December 2015 to February 2016,and applied random number table method to group patients averagely into observational group and control group,25 patients in each group. The patients of observational group received the enema treatment that triamcinolone acetonide combined with metronidazole,and the patients of control group received metronidazole enema treatment. This study lasted 7 days. We observed the patients’ clinical symptomatic remissions of the two groups after treatment,and checks as well as compare the patients'serum inflammatory cytokines of the two groups. Results The clinical symptomatic remissions of observational group patients were much better than that of control group,and the level of serum interleukin-8 was lower than that of control group,while its level of serum interleukin-10 was higher than that of control group. Comparative differences between the two both had statistical significance(P<0.05). Conclusion The enema treatment of trimcinolone actonide combining with metronidazole can effectively relieve the clinical symptom of patients with ulcerative proctitis.
【Key words】 Ulcerative proctitis,Triamcinolone acetonide,Curative effect observation
根据相关文献报道,大部分溃疡性结肠炎患者都是从直肠开始发病的,因此患者需在溃疡性直肠炎发病阶段就应开始接受正规的治疗[1]。本研究提出了采用曲安奈德联合甲硝锉灌肠治疗溃疡性直肠炎的方法,具体研究结果如下。
1.1一般资料
本研究从2015年12月~2016年2月至我院诊治的溃疡性直肠炎患者中选出了50例作为研究对象,采用随机数字表法将其均分为了观察组与对照组,每组25例患者。在观察组中14例女性,11例男性,患者年龄34~71岁,平均年龄(42.2±5.0)岁,平均病程(4.2±0.9)年;……